Group One Trading, L.P. Cara Therapeutics, Inc. Transaction History

Group One Trading, L.P.

$3.01 Billion
Q2 2024

A detailed history of Group One Trading, L.P. transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 34,775 shares of CARA stock, worth $10,432. This represents 0.0% of its overall portfolio holdings.

Number of Shares

34,775

Previous 39,975 13.01%

Holding current value

$10,432

Previous $36,000 75.0%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.24 - $0.92 $1,248 - $4,784	-5,200 Reduced 13.01%	34,775 $9,000
Q1 2024 May 10, 2024	BUY	$0.52 - $1.05 $26 - $52	50 Added 0.13%	39,975 $36,000
Q4 2023 Feb 14, 2024	SELL	$0.6 - $1.65 $5,100 - $14,025	-8,500 Reduced 17.55%	39,925 $29,000
Q3 2023 Nov 09, 2023	SELL	$1.67 - $3.33 $41,539 - $82,830	-24,874 Reduced 33.93%	48,425 $81,000
Q2 2023 Aug 09, 2023	BUY	$2.83 - $4.94 $67,665 - $118,115	23,910 Added 48.41%	73,299 $207,000
Q1 2023 May 12, 2023	SELL	$4.89 - $12.27 $111,995 - $281,019	-22,903 Reduced 31.68%	49,389 $242,000
Q4 2022 Feb 09, 2023	BUY	$8.88 - $12.77 $172,875 - $248,606	19,468 Added 36.85%	72,292 $776,000
Q3 2022 Nov 09, 2022	SELL	$8.24 - $12.56 $124,349 - $189,542	-15,091 Reduced 22.22%	52,824 $494,000
Q2 2022 Aug 11, 2022	BUY	$7.45 - $13.84 $182,606 - $339,232	24,511 Added 56.47%	67,915 $620,000
Q1 2022 May 12, 2022	BUY	$9.94 - $12.65 $116,198 - $147,878	11,690 Added 36.86%	43,404 $527,000
Q4 2021 Feb 11, 2022	BUY	$11.99 - $18.14 $380,250 - $575,291	31,714 New	31,714 $386,000
Q3 2021 Nov 12, 2021	SELL	$11.55 - $16.06 $204,908 - $284,920	-17,741 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$12.38 - $29.19 $145,588 - $343,274	-11,760 Reduced 39.86%	17,741 $253,000
Q1 2021 May 12, 2021	SELL	$15.07 - $21.71 $217,957 - $313,991	-14,463 Reduced 32.9%	29,501 $640,000
Q4 2020 Feb 10, 2021	SELL	$12.72 - $16.16 $2,862 - $3,636	-225 Reduced 0.51%	43,964 $665,000
Q3 2020 Nov 12, 2020	SELL	$12.34 - $17.92 $89,403 - $129,830	-7,245 Reduced 14.09%	44,189 $562,000
Q2 2020 Aug 13, 2020	BUY	$12.39 - $17.33 $13,269 - $18,560	1,071 Added 2.13%	51,434 $880,000
Q1 2020 May 13, 2020	SELL	$9.12 - $17.78 $545,759 - $1.06 Million	-59,842 Reduced 54.3%	50,363 $665,000
Q4 2019 Feb 10, 2020	BUY	$16.11 - $25.98 $1.32 Million - $2.13 Million	81,981 Added 290.47%	110,205 $1.78 Million
Q3 2019 Nov 12, 2019	SELL	$18.28 - $26.91 $499,884 - $735,880	-27,346 Reduced 49.21%	28,224 $516,000
Q2 2019 Aug 09, 2019	BUY	$17.68 - $21.57 $529,958 - $646,560	29,975 Added 117.11%	55,570 $1.2 Million
Q1 2019 May 13, 2019	BUY	$14.41 - $19.64 $36,687 - $50,003	2,546 Added 11.05%	25,595 $502,000
Q4 2018 Feb 06, 2019	BUY	$12.45 - $23.47 $286,960 - $540,960	23,049 New	23,049 $300,000
Q2 2018 Aug 14, 2018	SELL	$11.6 - $19.27 $82,290 - $136,701	-7,094 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$11.77 - $16.08 $83,496 - $114,071	7,094 New	7,094 $88,000

Others Institutions Holding CARA

# of Institutions

Shares Held

16.5M

Call Options Held

55K

Put Options Held

500

View Full List

About Cara Therapeutics, Inc.

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $16.1M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

More about CARA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Cara Therapeutics, Inc. Transaction History